Literature DB >> 11316694

Acute neurology and neurophysiology of haemolytic-uraemic syndrome.

K J Eriksson1, S G Boyd, R C Tasker.   

Abstract

Involvement of the central nervous system (CNS) is found in around 30% of children with haemolytic-uraemic syndrome (HUS). This complication is the single most common cause of mortality and also a major contributor to the morbidity associated with HUS. We reviewed 22 children with HUS and acute CNS involvement. Both global and focal derangements occurred, and in survivors, early regional EEG abnormalities-especially those in the occipital and temporal areas-were prognostically useful.

Entities:  

Mesh：

Year:  2001        PMID： 11316694      PMCID： PMC1718775          DOI： 10.1136/adc.84.5.434

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  9 in total

1.  Hemolytic-uremic syndrome in adolescents.

Authors:  R L Siegler; A T Pavia; J B Cook
Journal:  Arch Pediatr Adolesc Med       Date:  1997-02

2.  Adult-onset temporal lobe epilepsy associated with smoldering herpes simplex 2 infection.

Authors:  M E Cornford; G F McCormick
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

3.  EEG and seizures in children with hemolytic-uremic syndrome.

Authors:  A Dhuna; A Pascual-Leone; D Talwar; F Torres
Journal:  Epilepsia       Date:  1992 May-Jun       Impact factor: 5.864

Review 4.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

5.  EEG correlation of improvement in hemolytic-uremic syndrome after plasma infusion.

Authors:  A Pascual-Leone; A K Dhuna; S T Janousek; D Talwar
Journal:  Pediatr Neurol       Date:  1990 Jul-Aug       Impact factor: 3.372

6.  Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome.

Authors:  N Cimolai; B J Morrison; J E Carter
Journal:  Pediatrics       Date:  1992-10       Impact factor: 7.124

7.  Neurological involvement in hemolytic-uremic syndrome.

Authors:  K J Sheth; H M Swick; N Haworth
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

8.  CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.

Authors:  J F Bale; C Brasher; R L Siegler
Journal:  Am J Dis Child       Date:  1980-09

Review 9.  Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome.

Authors:  E G Gallo; C A Gianantonio
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714
  9 in total
  26 in total

1.  Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Cristina Felice Civitillo; Francesca Tel; Ilaria Possenti; Mirco Belingheri; Pierangela Castorina; Nicolò Bolsa-Ghiringhelli; Silvana Tedeschi; Fabio Paglialonga; Stefania Salardi; Dario Consonni; Elena Zoia; Patrizia Salice; Giovanna Chidini
Journal:  Pediatr Nephrol       Date:  2014-08-23       Impact factor: 3.714

2.  Neonatal hemolytic uremic syndrome after mother-to-child transmission of Escherichia coli O157.

Authors:  Tim Ulinski; Cyril Lervat; Bruno Ranchin; Yves Gillet; Daniel Floret; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2005-07-12       Impact factor: 3.714

3.  Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement.

Authors:  Frank Donnerstag; Xiaoqi Ding; Lars Pape; Eva Bültmann; Thomas Lücke; Jan Zajaczek; Ludwig Hoy; Anibh Martin Das; Heinrich Lanfermann; Jochen Ehrich; Hans Hartmann
Journal:  Eur Radiol       Date:  2011-10-08       Impact factor: 5.315

4.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

5.  Neurological involvement in a child with atypical hemolytic uremic syndrome.

Authors:  Bérengère Koehl; Olivia Boyer; Nathalie Biebuyck-Gougé; Manoelle Kossorotoff; Véronique Frémeaux-Bacchi; Nathalie Boddaert; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2010-08-17       Impact factor: 3.714

6.  Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha.

Authors:  Verónica I Landoni; Marcelo de Campos-Nebel; Pablo Schierloh; Cecilia Calatayud; Gabriela C Fernandez; M Victoria Ramos; Bárbara Rearte; Marina S Palermo; Martín A Isturiz
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

7.  CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings.

Authors:  Marc Steinborn; Steffen Leiz; Klaus Rüdisser; Martin Griebel; Thomas Harder; Helmut Hahn
Journal:  Pediatr Radiol       Date:  2004-07-29

8.  Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104:H4.

Authors:  U Löbel; B Eckert; O Simova; M Meier-Cillien; S Kluge; C Gerloff; J Röther; T Magnus; J Fiehler
Journal:  Clin Neuroradiol       Date:  2013-06-29       Impact factor: 3.649

9.  Quantitative MRI shows cerebral microstructural damage in hemolytic-uremic syndrome patients with severe neurological symptoms but no changes in conventional MRI.

Authors:  Karin Weissenborn; Eva Bültmann; Frank Donnerstag; Anja M Giesemann; Friedrich Götz; Hans Worthmann; Meike Heeren; Jan Kielstein; Anke Schwarz; Heinrich Lanfermann; Xiao-Qi Ding
Journal:  Neuroradiology       Date:  2013-04-05       Impact factor: 2.804

10.  Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.

Authors:  Angela Bauer; Sebastian Loos; Carola Wehrmann; Dirk Horstmann; Frank Donnerstag; Johanna Lemke; Georg Hillebrand; Ulrike Löbel; Lars Pape; Dieter Haffner; Carola Bindt; Thurid Ahlenstiel; Anette Melk; Anja Lehnhardt; Markus J Kemper; Jun Oh; Hans Hartmann
Journal:  Pediatr Nephrol       Date:  2014-03-25       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.